Population Pharmacokinetic Analysis and Model-Based Simulations of Aripiprazole for a 1-Day Initiation Regimen for the Long-Acting Antipsychotic Aripiprazole Lauroxil-Reference-Cited by-同舟云学术

Population Pharmacokinetic Analysis and Model-Based Simulations of Aripiprazole for a 1-Day Initiation Regimen for the Long-Acting Antipsychotic Aripiprazole Lauroxil

Published:2018-06-11 Issue:4 Volume:43 Page:461-469
ISSN:0378-7966
Container-title:European Journal of Drug Metabolism and Pharmacokinetics
language:en
Short-container-title:Eur J Drug Metab Pharmacokinet

Author:

Hard Marjie L.,Wehr Angela Y.,Sadler Brian M.,Mills Richard J.,von Moltke Lisa

Funder

Alkermes, Inc.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Link

http://link.springer.com/article/10.1007/s13318-018-0488-4/fulltext.html

Reference13 articles.

1. Weiden PJ, Kozma C, Grogg A, Locklear J. Partial compliance and risk of rehospitalization among California Medicaid patients with schizophrenia. Psychiatr Serv. 2004;55:886–91.

2. Heslin KC WA. Hospital Readmissions Involving Psychiatric Disorders, 2012. HCUP Statistical Brief #189. 2015. http://www.hcup-us.ahrq.gov/reports/statbriefs/sb189-Hospital-Readmissions-Psychiatric-Disorders-2012.pdf . Accessed 25 May 2018.

3. Brissos S, Veguilla MR, Taylor D, Balanzá-Martinez V. The role of long-acting injectable antipsychotics in schizophrenia: a critical appraisal. Ther Adv Psychopharmacol. 2014;4:198–219.

4. Alkermes Inc. Aristada (Aripiprazole Lauroxil) Prescribing Information. 2018. https://www.aristadahcp.com/downloadables/ARISTADA-PI.pdf . Accessed 25 May 2018.

5. Cruz MP. Aripiprazole lauroxil (Aristada): an extended-release, long-acting injection for the treatment of schizophrenia. Pharm Ther. 2016;41:556–9.

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How drug onset rate and duration of action affect drug forgiveness;Journal of Pharmacokinetics and Pharmacodynamics;2024-01-10

2. Switching to long-acting injectable antipsychotics: pharmacological considerations and practical approaches;Expert Opinion on Pharmacotherapy;2023-06-27

3. Therapeutic Reference Range for Aripiprazole in Schizophrenia Revised: a Systematic Review and Metaanalysis;Psychopharmacology;2022-10-05

4. Should patients skip late doses of medication? A pharmacokinetic perspective;Journal of Pharmacokinetics and Pharmacodynamics;2022-06-20

5. A pharmacokinetic and pharmacodynamic analysis of drug forgiveness;Journal of Pharmacokinetics and Pharmacodynamics;2022-02-13